Richtlinie Urologie

Universitäres Zentrum für Uro-Onkologie
am Inselspital Bern
Studienliste
Liste
Studie
Entität
Klinik
Principal
investigator
Co-investigator
Verantwortliche
study nurse
18F-FDG
PET/CT versus CT imaging in
staging of primary Muscle Invasive
Bladder Cancer
Blasenkarzinom
Urologie
Seiler
Thalmann, Kiss
N.A.
Geplant
10/2013
Carboplatin Chemotherapy and Involved Node Radiotherapy in Stage
IIA/B Seminoma (SAKK 01/10)
Hodentumor
(Seminom)
Radioonkologie,
Med. Onkologie
Aebersold
E.Herrmann
Nannen,
Timo (Rad Onc)
An European randomized phase 3
Study to assest he efficacy and safty of
TOOKAD soluble for localized prostate
cancer compared to active surveillance
Prostatakarzinom (Fokaltherapie)
Urologie
Thalmann
Zehender
Sentinel-LymphknotenFluoreszenzdetektion beim Prostata-Ca
(ICG-LK-Detektion)
Prostatakarzinom
Urologie
Thalmann
Metzger/Nguyen
STAMPEDE: Systemic Therapy in
Advancing or Metastatic Prostate
Cancer: Evaluation of Drug Efficacy: A
Multi-Stage Multi-Arm Randomised
Controlled Trial
Prostatakarzinom
Urologie
Thalmann
Post-operative external radiotherapy
combined with concomitant and adjuvant hormonal treatment versus postoperative external radiotherapy alone in
pathological stage pT3a-b R0-1 N0M0 /
Prostatakarzinom
Radioonkologie
uro-onkologie-studienliste_KRO_TN_AD_CV (3)
Med. Onkologie
Aebersold
NA
Genehmigt durch: Spahn, DelPra, Schardt, Ochsner
Datum Ende
Patientenzahl pro
Kalenderjahr
Q 2/2012
Q 2/2015
Total 115 geplant
Fr. Hermann
12/2012
Rekrutierungsphase
endet voraussichtlich 07/2013 (anschliessend evtl
Verlängerung)
1
N.A.
2/2013
offen
open
Fr. Ochsner
Antje Ulrich,
(UKMO),
Nannen,
Timo (Rad Onc)
December
2005
September 2017
temp. closed
Nannen,
Timo (Rad Onc)
Q I/2009
Q I/2014
Total 600 geplant
SV study nurse
Datum:29.06.2013, Version 0.0-Entwurf
Datum Start
Seite 1 von 2
Universitäres Zentrum für Uro-Onkologie
am Inselspital Bern
Studienliste
Liste
pT2R1 N0M0, Gleason score 5-10
prostatic carcinoma. A Phase III study
(EORTC 22043-30041
Dose intensified salvage radiotherapy in
biochemically relapsed prostate cancer
without macroscopic disease. A randomized phase III trial (SAKK 09/10)
SAKK 08/11: Orteronel maintenance therapy in patients with
metastatic castration resistant
prostate cancer and nonprogressive disease after firstline docetaxel therapy: A multicenter randomized double-blind
placebo-controlled phase III trial
Prostatakarzinom
Radioonkologie,
Urologie
E. Herrmann
Prostatakarzinom
Med. Onkologie
Ochsenbein
uro-onkologie-studienliste_KRO_TN_AD_CV (3)
Aebersold
Genehmigt durch: Spahn, DelPra, Schardt, Ochsner
Nannen,
Timo (Rad Onc)
Q I/2011
Q I/2015
Total 350 geplant
Antje Ulrich
Q1/2013
Q4 2016
open
Datum:29.06.2013, Version 0.0-Entwurf
Seite 2 von 2